Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders

  Abstract: The emergence of direct-acting antiviral (DAA) therapies and noninvasive measures of liver fibrosis has streamlined the management of patients with chronic hepatitis C virus […]

Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection

  Abstract: In 2016, the US Food and Drug Administration issued a warning about the risk of hepatitis B virus (HBV) reactivation in some patients receiving […]

Extrahepatic Benefits Achieved With Sustained Virologic Response in Patients With Hepatitis C Virus Infection

  G&H  What are the hepatic benefits achieved with sustained virologic response in patients infected with hepatitis C virus? MK  In patients with chronic hepatitis C […]

Hepatitis C Virus and Liver Transplantation

  Abstract: Hepatitis C virus (HCV) is a major cause of death from infectious disease and is still the leading indication for liver transplantation in the […]

Hepatitis C Virus Infection in Children

  G&H  What is the prevalence of hepatitis C virus infection in children? KM  In comparison to adults, the prevalence of this disease is relatively low […]

Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States

  Abstract: Background and Aims: Approximately half of adults with hepatitis C in the United States do not know their infection status, and the majority of […]

New Therapies for Hepatitis C Virus Infection

  Abstract:  Approximately 350 million people worldwide are infected with hepatitis C virus (HCV), which is associated with morbidity and mortality related to cirrhosis, hepatocellular carcinoma, […]

Millennium Medical Publishing, Inc